Oscar Larrainzar walked into UCLA Medical Center six months ago with failing kidneys and a bladder so damaged he faced a lifetime dependent on complex, high-risk reconstructive surgery — today, he urinates spontaneously, his transplanted kidney functions steadily, and his new bladder, fully connected to its own blood supply, is doing what no transplanted bladder has done before: working like a natural one. At 41, Larrainzar is the world’s first patient to receive a fully vascularized bladder graft transplanted alongside a kidney, a groundbreaking procedure led by Dr. Nima Nassiri in Los Angeles and now documented in The Lancet. This milestone isn’t just a medical first — it’s a beacon of hope for thousands with end-stage bladder disease who’ve long relied on bowel-based urinary diversions that carry lifelong risks of infection, metabolic imbalance, and kidney damage.
For decades, patients with non-functional bladders due to trauma, disease, or congenital conditions have had limited options: surgeons reroute urine through segments of the intestine, creating neobladders or urinary conduits. While life-saving, these methods come with significant downsides — the bowel wasn’t designed to store urine, and over time, complications like dehydration, vitamin deficiencies, and recurrent infections often arise. The idea of transplanting a true, vascularized bladder — one with its own blood vessels, like a kidney or liver — has been a theoretical goal for years. Now, for the first time, it’s real. In May 2025, Dr. Nassiri and his team performed an eight-hour surgery at UCLA, transplanting both a kidney and a donor bladder as distinct, fully vascularized organs. From the moment blood flow was restored, the kidney began filtering waste, and the bladder showed strong perfusion, a sign of immediate viability.
Six months later, Larrainzar’s recovery continues to astonish. He has functional bladder storage and voids spontaneously — a critical sign of neural integration and muscle function. His kidney remains stable on standard immunosuppression, with no evidence of rejection in either organ. The success of this single-patient feasibility trial, published in The Lancet in 2026, proves that combined bladder-kidney transplantation is not only possible but functionally promising. Researchers emphasize that this is just the beginning: larger clinical trials are already in motion, aiming to refine surgical techniques, improve long-term outcomes, and expand access to patients who could benefit. For now, Larrainzar’s case stands as a quiet revolution — one that could one day redefine how medicine rebuilds the urinary system.